CSF3 and neutropenia: However, the irinotecan/cisplatin regimen was associated with a significantly higher incidence of grade 3 and 4 neutropenia and neutropenic fever than cisplatin monotherapy, leading to a higher proportion of patients requiring prophylactic use of G-CSF.